Nucleosides, Nucleotides and Nucleic Acids as Therapeutics: A Virtual Special Issue

Affiliations

Editorial

Amanda L Garner. ACS Pharmacol Transl Sci. 2021.

. 2021 Nov 9;4(6):1714-1715.

doi: 10.1021/acsptsci.1c00231. eCollection 2021 Dec 10.

¹ Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, United States.

No abstract available

References

1. Shelton J.; Lu X.; Hollenbaugh J. A.; Cho J. H.; Amblard F.; Schinazi R. F. Metabolism, biochemical actions, and chemical synthesis of anticancer nucleosides, nucleotides, and base analogs. Chem. Rev. 2016, 116, 14379.10.1021/acs.chemrev.6b00209. - DOI - PMC - PubMed
1. Thornton P. J.; Kadri H.; Miccoli A.; Mehellou Y. Nucleoside phosphate and phosphonate prodrug clinical candidates. J. Med. Chem. 2016, 59, 10400–10410. 10.1021/acs.jmedchem.6b00523. - DOI - PubMed
1. Jordheim L. P.; Durantel D.; Zoulim F.; Dumontet C. Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases. Nat. Rev. Drug Discovery 2013, 12, 447–464. 10.1038/nrd4010. - DOI - PubMed
1. Setten R. L.; Rossi J. J.; Han S. P. The current state and future directions of RNAi-based therapeutics. Nat. Rev. Drug Discovery 2019, 18, 421–446. 10.1038/s41573-019-0017-4. - DOI - PubMed
1. Crooke S. T.; Baker B. F.; Crooke R. M.; Liang X.-H. Antisense technology: an overview and prospectus. Nat. Rev. Drug Discovery 2021, 20, 427–453. 10.1038/s41573-021-00162-z. - DOI - PubMed